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Aberrant growth stimulation by Signal Transducers and
Activators of Transcription (STAT) is implicated in human
carcinogenesis. The viral effector oncoprotein Tip, which
binds to and is phosphorylated by the T-cell lymphocyte
kinase Lck, is crucial in the activation of the cellular STAT5
signalling pathway in Herpesvirus-transformed T-cell
lines, a model for malignant T-cell proliferation. While
Tip-Lck interaction is required for transformation by HVS,
mutation of Tip tyrosine residues had distinct effects. Two
defined mutations of Tip can direct the phosphorylation
and activation of either STAT3 or STAT5 by Lck. Tip Y114
mutation to phenylalanine (TipY114F) abolished the
constitutive STAT3 activation observed in HVS-wildtype
transformed T cells. Conversely, TipY114F enhanced the
efficiency of human T cell transformation in absence of
exogenous interleukin-2 (IL-2). In contrast, mutation of
the major phosphorylation site, Y127, in Tip is compati-
ble with viral transformation only when IL-2 is supple-
mented. This growth factor requirement correlated with
STAT5 activation by Lck and Tip. Our current work focuses
on the synergy among Tip, Lck, STAT5 and JAK family
kinases. Interaction analysis will address whether Tip or
the Y127F mutant mediate interactions between STAT5
and Lck or other Src family members. The role of the JAK-
STAT pathway was elucidated using specific JAK inhibi-
tors. We assume that, for viral transformation, Tip prefer-
entially targets and reprograms the STAT5 pathway, which
is central for T-cell growth and homeostasis. Comparable
modulation of the STAT5 signalling may be involved in
other forms of malignancy and cell differentiation; their
analysis may therefore be a useful model for the develop-
ment of new therapeutics.
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